Page last updated: 2024-11-05

diacetamate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

diacetamate: cpd is acetaminophen acetate [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID17499
CHEMBL ID2106185
SCHEMBL ID863106
MeSH IDM0092874

Synonyms (83)

Synonym
diacetamat
nsc6083
acetamide, n-[4-(acetyloxy)phenyl]-
2623-33-8
acetanilide, acetate (ester)
acetaminophen acetate
nsc-6083
4-acetamidophenyl acetate
p-acetoxyacetanilide
n-acetyl-4-aminophenyl acetate
4-acetoxyacetanilide
diacetamate
nsc33893
nsc-33893
AG-670/32634053
4-(acetylamino)phenyl acetate
NCGC00160605-01
MAYBRIDGE1_006198
inchi=1/c10h11no3/c1-7(12)11-9-3-5-10(6-4-9)14-8(2)13/h3-6h,1-2h3,(h,11,12
4'-acetoxyacetanilide
A0067
n,o-diacetyl-4-aminophenol
STL034244
HMS559B16
(4-acetamidophenyl) acetate
FT-0661040
AKOS002255264
HMS3264O15
ai3-17250
diacetamatum [inn-latin]
bfg1ty61bg ,
acetamide, n-(4-(acetyloxy)phenyl)-
nsc 33893
diacetamatum
einecs 220-077-6
diacetamate [inn:ban]
unii-bfg1ty61bg
diacetamato
nsc 6083
acetanilide, 4'-hydroxy-, acetate (ester)
diacetamato [inn-spanish]
dtxsid2046256 ,
tox21_111931
dtxcid0026256
cas-2623-33-8
nsc-758889
pharmakon1600-01504515
nsc758889
CHEMBL2106185
n,o-diacetyl-4-aminopheno
F3228-0190
acetaminophen acetate (acetaminophen impurity)
4'-hydroxyacetanilide acetate
o-acetylparacetamol
n-[4-(acetyloxy)phenyl]acetamide
acetamide,n-[4-(acetyloxy)phenyl]-
paracetamol impurity h [ep impurity]
diacetamate [inn]
SCHEMBL863106
CCG-213946
MLS006011695
smr002530013
acetanilide, 4'-hydroxy-, acetate
AB01563223_01
VU0606051-1
mfcd00059205
o,n-diacetyl-4-aminophenol
SR-01000872731-1
sr-01000872731
4-(acetylamino)phenyl acetate (n,o-diacetyl-4-aminophenol)
J-016335
SBI-0207076.P001
3-(4-methylbenzoyl)acrylicacid
F17539
CS-0005650
HY-66004
acetic acid 4-acetylamino-phenyl ester
AS-48014
BRD-K93611241-001-01-4
Q27274637
EN300-7392397
Z29109552
SY105212

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (40.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.42

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.42 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index42.09 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (33.42)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]